Patent Assignment
Reel/Frame 059041/0865
Assignment of Assignor's Interest
Recorded: 2022-02-17
Pages: 5
Assignor
BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
Executed: 2022-01-11
Assignees
BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
UNIT A-738, BUILDING NO.2, NO. 22 TONGJI NORTH ROAD, BEIJING ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA, BEIJING, 101111, CHINA
GENRIX (SHANGHAI) BIOPHARMACEUTICAL CO., LTD.
5/F, BUILDING 1, 581 SHENKUO ROAD, CHINA (SHANGHAI) PILOT FREE TRADE ZONE, SHANGHAI, 201203, CHINA
CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
BLOCK A, BUILDING 2, NO. 699, MALIU AVENUE, BANAN DISTRICT, CHONGQING, CHINA
Covered Property
(1)
Anti-CD3E/Bcma Bispecific Antibody and Use Thereof
Application:
17/620,290 →
Publication:
US 2023/0212287
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2022
From: LIU, ZHIGANG; WAN, SHUNAN; LIU, YULAN; HAO, XIAOBO
To: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.
Reel/Frame 059041/0818 →
Assignment of Assignor's Interest
May 22, 2025
From: BEIJING WISDOMAB BIOTECHNOLOGY CO., LTD.; GENRIX (SHANGHAI) BIOPHARMACEUTICAL CO., LTD.
To: CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.
Reel/Frame 071351/0777 →